Abstract Objective Th1 activation based on a high HTLV-I proviral load is one of the characteristic immunological abnormalities in the peripheral blood lymphocytes of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). To clarify the cause of this abnormality with the potential to be one of the therapeutic targets, we analyzed the involvement of interleukin-2 (IL-2)/IL-2 receptor (IL-2R) signaling in HTLV-I and interferon-γ (IFN-γ), which is a representative Th1 cytokine, expression in peripheral blood CD4 + T cells from HAM/TSP patients.
Introduction

Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is chronic progressive myelopathy characterized by bilateral pyramidal tract involvement and sphincteric disturbances (1). The main pathological feature of HAM/TSP is chronic inflammation of the spinal cord (2); however, it remains unclear why such chronic inflammation is induced in only a small proportion of HTLV-I-infected individuals. Numerous studies have revealed immunological abnormalities related to a high HTLV-I proviral load in peripheral blood lymphocytes from HAM/TSP patients (3). HTLV-I preferentially infects CD4 + T cells (4) and interleukin-2 receptors (IL-2R) are expressed on the surfaces of HTLV-Iinfected CD4 + T cells through the transactivation by HTLV-I tax (5). Although increased spontaneous peripheral blood lymphocyte (PBL) proliferation seems to be one of the most characteristic immunological abnormalities in PBL of HAM/ TSP patients (6), this phenomenon relies on the activation of the autocrine loop of IL-2/IL-2R
and IL-15/IL-15R (8 
Patients and Methods
Patients
Treatment of peripheral blood CD4 T cells with anti-IL-2Rα, β, and γ blocking antibody
To determine the appropriate concentration of anti-IL-2R blocking antibodies (R & D Systems, Minneapolis, MN) for the suppression of HTLV-I p19 antigen and IFN-γ expression, an IL-2-dependent HTLV-I-producing T cell line derived from a HAM/TSP patient (HCT-1) was treated with different concentrations of anti-IL-2R blocking antibodies, and the levels of HTLV-I p19 antigen and IFN-γ in each culture supernatant were determined (data not shown
Measurement of HTLV-I p19 antigen and IFN-γ levels in culture supernatants
Statistical analysis
The Wilcoxon-signed rank test was used for statistical analysis. Differences were considered statistically significant at p<0.05. 
Results
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tibodies suppressed cell viability in our experiment system, such as 48-hour culture (Fig. 1b) , indicating that treatment with these antibodies did not inhibit cell proliferation.
Effect of anti-IL-2R blocking antibody on IFN-γ expression on peripheral blood CD4 T cells from HAM/TSP patients
In the case of IFN-γ expression, the treatment of peripheral blood CD4 + T cells from HAM/TSP patients with anti-IL-2Rα antibody significantly suppressed IFN-γ expression in peripheral blood CD4 + T cells of all HAM/TSP patients by about 21-99% in the same manner as the effect on HTLV-I p19 antigen expression (Fig. 2). In addition, the treatment of peripheral blood CD4 + T cells from HAM/TSP patients with anti-IL-2Rβ or anti-IL-2Rγ blocking antibody also significantly suppressed IFN-γ expression in peripheral blood CD4
+ T cells of all HAM/TSP patients (Fig. 2) . As shown in Fig. 1b, 
